Search research articles
Contact Us
Filters
Showing results (81-90 of 92) with videos related to
Page
of 10
Sort By:
The Lancet. Oncology
|
February 19, 2026
Nomogram-based risk classification for predicting response to metastasis-directed stereotactic body radiotherapy in PSMA PET-staged oligorecurrent prostate cancer (PORTAL): an international, retrospective cohort study
Timo F W Soeterik, Marcin Miszczyk, Max Peters, et al.
Technical Innovations & Patient Support in Radiation Oncology
|
September 12, 2022
Online adaptive MR-guided radiotherapy: Conformity of contour adaptation for prostate cancer, rectal cancer and lymph node oligometastases among radiation therapists and radiation oncologists
Marnix J A Rasing, Gonda G Sikkes, Nicole G P M Vissers, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
October 31, 2024
Locoregional control in high-risk neuroblastoma using highly-conformal image-guided radiotherapy, with reduced margins and a boost dose for residual lesions
Atia Samim, Annemieke S Littooij, Max Peters, et al.
European Urology
|
February 6, 2022
Cancer Control Outcomes Following Focal Therapy Using High-intensity Focused Ultrasound in 1379 Men with Nonmetastatic Prostate Cancer: A Multi-institute 15-year Experience
Deepika Reddy, Max Peters, Taimur T Shah, et al.
CA: a Cancer Journal for Clinicians
|
May 16, 2026
Twenty-year results of the randomized European Organization for Research and Treatment of Cancer trial 22922/10925 evaluating internal mammary chain and medial supraclavicular lymph node irradiation in stage I-III breast cancer
Orit Kaidar-Person, Caroline G Weltens, Catherine Fortpied, et al.
BJU International
|
June 29, 2023
External validation of a risk model predicting failure of salvage focal ablation for prostate cancer
Alexander Light, Max Peters, Deepika Reddy, et al.
The Lancet. Oncology
|
June 29, 2026
Internal mammary chain and medial supraclavicular lymph node irradiation in stage I-III breast cancer (EORTC trial 22922/10925): an unplanned subset analysis of 20-year outcomes in patients with node-negative breast cancer
Orit Kaidar-Person, Caroline G Weltens, Catherine Fortpied, et al.
Prostate Cancer and Prostatic Diseases
|
January 28, 2021
Focal therapy compared to radical prostatectomy for non-metastatic prostate cancer: a propensity score-matched study
Taimur T Shah, Deepika Reddy, Max Peters, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
September 4, 2021
Risk factors for nodal failure after radiochemotherapy and image guided brachytherapy in locally advanced cervical cancer: An EMBRACE analysis
Max Peters, Astrid A C de Leeuw, Christel N Nomden, et al.
JAMA Oncology
|
February 12, 2026
Salvage Focal Therapy vs Radical Prostatectomy for Localized Radiorecurrent Prostate Cancer
Alexander Light, Max Peters, Manit Arya, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 92) with videos related to
Sort By:
Page
of 10
The Lancet. Oncology
|
February 19, 2026
Nomogram-based risk classification for predicting response to metastasis-directed stereotactic body radiotherapy in PSMA PET-staged oligorecurrent prostate cancer (PORTAL): an international, retrospective cohort study
Timo F W Soeterik, Marcin Miszczyk, Max Peters, et al.
Technical Innovations & Patient Support in Radiation Oncology
|
September 12, 2022
Online adaptive MR-guided radiotherapy: Conformity of contour adaptation for prostate cancer, rectal cancer and lymph node oligometastases among radiation therapists and radiation oncologists
Marnix J A Rasing, Gonda G Sikkes, Nicole G P M Vissers, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
October 31, 2024
Locoregional control in high-risk neuroblastoma using highly-conformal image-guided radiotherapy, with reduced margins and a boost dose for residual lesions
Atia Samim, Annemieke S Littooij, Max Peters, et al.
European Urology
|
February 6, 2022
Cancer Control Outcomes Following Focal Therapy Using High-intensity Focused Ultrasound in 1379 Men with Nonmetastatic Prostate Cancer: A Multi-institute 15-year Experience
Deepika Reddy, Max Peters, Taimur T Shah, et al.
CA: a Cancer Journal for Clinicians
|
May 16, 2026
Twenty-year results of the randomized European Organization for Research and Treatment of Cancer trial 22922/10925 evaluating internal mammary chain and medial supraclavicular lymph node irradiation in stage I-III breast cancer
Orit Kaidar-Person, Caroline G Weltens, Catherine Fortpied, et al.
BJU International
|
June 29, 2023
External validation of a risk model predicting failure of salvage focal ablation for prostate cancer
Alexander Light, Max Peters, Deepika Reddy, et al.
The Lancet. Oncology
|
June 29, 2026
Internal mammary chain and medial supraclavicular lymph node irradiation in stage I-III breast cancer (EORTC trial 22922/10925): an unplanned subset analysis of 20-year outcomes in patients with node-negative breast cancer
Orit Kaidar-Person, Caroline G Weltens, Catherine Fortpied, et al.
Prostate Cancer and Prostatic Diseases
|
January 28, 2021
Focal therapy compared to radical prostatectomy for non-metastatic prostate cancer: a propensity score-matched study
Taimur T Shah, Deepika Reddy, Max Peters, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
September 4, 2021
Risk factors for nodal failure after radiochemotherapy and image guided brachytherapy in locally advanced cervical cancer: An EMBRACE analysis
Max Peters, Astrid A C de Leeuw, Christel N Nomden, et al.
JAMA Oncology
|
February 12, 2026
Salvage Focal Therapy vs Radical Prostatectomy for Localized Radiorecurrent Prostate Cancer
Alexander Light, Max Peters, Manit Arya, et al.
Page
of 10